Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MOREIn the context of TCR-T therapy, T cell persistence refers to the ability of TCR-T cells to persist in the body after infusion. The persistence of TCR-T cells is important for their efficacy, as they need to remain in the body in sufficient numbers to continue targeting and killing cancer cells, leading to long-term antitumor activity. Good persistence of TCR-T cells can improve the effective antitumor response. Several factors can influence TCR-T cell persistence, including TCR-T cell designs and manufacturing processes, the type of TCR-T cell, the type and stage of the cancer being treated, and the patient's immune system.
At Creative Biolabs, we provide T-cell persistence test services that can be used to detect TCR-T cell persistence in vivo. Our experts offer several methods to monitor circulating TCR T-cells into blood samples after treatment.
It is essential to understand and enhance TCR-T cell persistence thus improving the efficacy and durability of TCR-T cell therapies in treating cancer. T cell persistence test involves the detection and quantification of TCR T cells in blood samples. At Creative Biolabs, we monitor TCR T-cell persistence over time with several techniques, including flow cytometry, qPCR, and ddPCR. By combining multiple techniques, we aim to provide comprehensive information on TCR-T cell persistence and function, which is crucial for the optimization of TCR-T cell therapies. The following are some reliable methods of tracking TCR T cell numbers.
Fig.1 T Cell Persistence Tests.
Flow cytometry enables the identification of surface epitopes on live TCR T-cells. This method involves staining the TCR-T cells with fluorescent antibodies specific to the TCR molecule and other cell surface markers. The stained cells are then analyzed using flow cytometry to quantify the number of TCR-T cells present in a sample.
qPCR is the gold standard for the detection and quantification of the integrated TCR transgene sequence in TCR-T cells. Monitoring TCR-T expansion/persistence through our qPCR assay gives you real-time data on the TCR-T therapy.
ddPCR is a powerful tool that can be used to determine the absolute number of TCR-T cells present in a blood sample. It enables the monitoring of TCR T-cell kinetics with high precision and sensitivity.
Here are some representative data for T-cell persistence tests.
Case 1: Analysis of CAR-T Cell Persistence by ddPCR
Fig.2 CAR-T cell persistence with time was assessed by ddPCR.1
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
